Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Daiichi Sankyo
- Hansoh Pharmaceutical Group
Comparative performance (base 100)
Each asset is worth 100 at October 20, 2025; a value of 120 means +20% since that date (latest common date: October 16, 2026).
Each performance is calculated in the asset's trading currency, without currency conversion.
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | Daiichi SankyoStock | Hansoh Pharmaceutical GroupStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | −33.2% | −12.9% |
| Annualized performanceAverage annual return that would produce the same total performance. | −33.5% | −13.0% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 38.3% | 41.6% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −42.0% | −34.1% |
| Sharpe RatioReturn achieved above the risk-free rate (5.10%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | -0.95 | -0.28 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −3.9% | −4.0% |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 4.99T ¥ | 192.43B HKD |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 20.8 | 25.8 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 2.2 | 12.1 |
| Net marginShare of revenue retained as profit. | 10.9% | 42.0% |
| Return on equityReturn on equity (ROE). | 14.8% | 19.4% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +21.1% | +11.7% |
| Dividend yieldAnnual dividend relative to the share price. | 3.65% | 1.53% |
| Debt / equityFinancial debt relative to shareholders' equity. | 29% | 11% |
Correlations over the period
From −1 to 1: close to 1, the two assets rise and fall together; close to 0, they move independently.
- Daiichi Sankyo / Hansoh Pharmaceutical Group0.12
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.